GramEye Inc.

Program name

Deep-Tech Startups Support Program

Research theme

Commercialization development of Gram staining automated AI medical device and overseas demonstration project

Business Plan

In response to the problem of drug-resistant bacteria, which is a global medical issue, we provide AI-equipped medical devices that automate microbial testing "Gram staining". With the aim of acquiring mainstream customers in Japan and overseas, this project will provide paid samples to multiple innovator facilities, develop AI for estimating bacterial species, develop AI for estimating Mycobacterium tuberculosis, and develop business development for market expansion in the U.S. market.

Research Outline

In this R&D, we will achieve the following PoCs for AI-equipped medical devices that automate microbial testing "Gram staining" in order to make them products that will acquire mainstream customers in Japan and overseas.

(1)Notification of Magenta, an AI-powered automated gram staining device, as a medical device and introduction to innovator facilities

(2)Development of AI for estimation of bacterial species, collection of datasets for AI learning using paid samples

(3)Completion of development of Mycobacterium tuberculosis estimation AI and introduction to innovator facilities as paid samples

International collaborative technology demonstration

• Download this page（204KB）